1887

Chapter 117 : and

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

and , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap117-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap117-2.gif

Abstract:

The taxonomy of has been in flux, and this genus has now been subdivided into subgenera and sections. In practice, species are identified mainly on the basis of phenotypic characteristics of the anamorph. Early monographic treatments also included descriptions of the teleomorph. In general, colonies usually grow very rapidly, producing powdery white, green, yellowish, brown, or black colonies. Several species also produce mycotoxins which are harmful to humans and animals when ingested. still accounts for most cases of aspergillosis, with and being the other more common pathogenic species worldwide. There has also been an increase in reports demonstrating the recovery of previously recognized species, such as and , from human infections. Importantly, these species appear to have different in vitro susceptibility patterns and show differences in clinical disease. Enzyme-linked immunosorbent assay (ELISA) reactivity was reported for certain beta-lactam antibacterial agents and, more recently, for patients treated with piperacillintazobactam and amoxicillin-clavulanic acid. The ELISA reactivity observed in batches of these antibiotics might be due to the use of fungi for the production of the antibacterial agents. The internal transcribed spacer regions of rDNA have been found to be more discriminatory than the 28S ribosomal subunit for identification of 13 clinically important species. PCR-based assays utilizing these sequences have also been developed. , a member of the subgenus , is considered as the only true pathogen.

Citation: Arunmozhi Balajee S, Brandt M. 2011. and , p 1836-1852. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch117

Key Concept Ranking

Aspergillus fumigatus
0.47362396
Sandwich Enzyme-Linked Immunosorbent Assay
0.46326864
Aspergillus terreus
0.4472477
0.47362396
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Key to representative species of (Reprinted from reference with permission from the publisher.)

Citation: Arunmozhi Balajee S, Brandt M. 2011. and , p 1836-1852. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch117
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(A) Section of lung, stained with hematoxylin and eosin, showing dichotomously branched hyphae of in invasive aspergillosis. (B) colony on potato dextrose agar. (C) colony on potato dextrose agar. (D) showing cleistothecia. (E) colony on malt extract agar. (F) showing biseriate head, brown stipe, and Hülle cells. (G) Colony of showing diffusing red pigment on Sabouraud dextrose agar after 7 days. Note that several species produce diffusible red pigments. (H) Compact biverticillate penicillus of .

Citation: Arunmozhi Balajee S, Brandt M. 2011. and , p 1836-1852. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch117
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap117
1. Alcazar-Fuoli, L.,, E. Mellado,, A. Alastruey-Izquierdo,, M. Cuenca-Estrella,, and J. L. Rodriguez-Tudela. 2008. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob. Agents Chemother. 52:12441251.
2. Ansorg, R.,, R. van den Boom,, and R. M. Rath. 1997. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 40:353357.
3. Ascioglu, S.,, J. H. Rex,, B. de Pauw,, J. E. Bennett,, J. Bille,, F. Crokaert,, D. W. Denning,, J. P. Donnelly,, J. E. Edwards,, Z. Erjavec,, D. Fiere,, O. Lortholary,, J. Maertens,, J. F. Meis,, T. F. Patterson,, J. Ritter,, D. Selleslag,, P. M. Shah,, D. A. Stevens,, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:714.
4. Aufauvre-Brown, A.,, J. Cohen,, and D. W. Holden. 1992. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J. Clin. Microbiol. 30:29912993.
5. Baddley, J. W.,, T. P. Stroud,, D. Salzman,, and P. G. Pappas. 2001. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32:13191324.
6. Balajee, S. A.,, H. A. de Valk,, B. A. Lasker,, J. F. Meis,, and C. H. Klaassen. 2008. Utility of a microsatellite assay for identifying clonally related outbreak isolates of Aspergillus fumigatus. J. Microbiol. Methods 73:252256.
7. Balajee, S. A.,, J. L. Gribskov,, E. Hanley,, D. Nickle,, and K. A. Marr. 2005. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot. Cell 4:625632.
8. Balajee, S. A.,, J. Houbraken,, P. E. Verweij,, S. B. Hong,, T. Yaghuchi,, J. Varga,, and R. A. Samson. 2007. Aspergillus species identification in the clinical setting. Stud. Mycol. 59:3946.
9. Balajee, S. A.,, M. D. Lindsley,, N. Iqbal,, J. Ito,, P. G. Pappas,, and M. E. Brandt. 2007. Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods. J. Clin. Microbiol. 45:27012703.
10. Bart-Delabesse, E.,, M. Basile,, A. Al Jijakli,, D. Souville,, F. Gay,, B. Philippe,, P. Bossi,, M. Danis,, J. P. Vernant,, and A. Datry. 2005. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J. Clin. Microbiol. 43:52145220.
11. Bart-Delabesse, E.,, J. Sarfati,, J. P. Debeaupuis,, W. van Leeuwen,, A. van Belkum,, S. Bretagne,, and J. P. Latge. 2001. Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates. J. Clin. Microbiol. 39:26832686.
12. Brandt, M. E.,, L. Gade,, C. B. McCloskey,, and S. A. Balajee. 2009. Atypical Aspergillus flavus isolates associated with chronic azole therapy. J. Clin. Microbiol. 47:33723375.
13. Buchheidt, D.,, M. Hummel,, D. Schleiermacher,, B. Spiess,, R. Schwerdtfeger,, O. A. Cornely,, S. Wilhelm,, S. Reuter,, W. Kern,, T. Sudhoff,, H. Morz,, and R. Hehlmann. 2004. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br. J. Haematol. 125:196202.
14. Buffington, J.,, R. Reporter,, B. A. Lasker,, M. M. McNeil,, J. M. Lanson,, L. A. Ross,, L. Mascola,, and W. R. Jarvis. 1994. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr. Infect. Dis. J. 13:386393.
15. Cao, L.,, K. M. Chan,, D. Chen,, N. Vanittanakom,, C. Lee,, C. M. Chan,, T. Sirisanthana,, D. N. Tsang,, and K. Y. Yuen. 1999. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J. Clin. Microbiol. 37:981986.
16. Cao, L.,, D. L. Chen,, C. Lee,, C. M. Chan,, K. M. Chan,, N. Vanittanakom,, D. N. Tsang,, and K. Y. Yuen. 1998. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis. J. Clin. Microbiol. 36:30283031.
17. Chandler, F. W.,, and J. C. Watts. 1987. Pathologic Diagnosis of Fungal Infections. American Society of Clinical Pathologists, Inc., Chicago, IL.
18. Chariyalertsak, S.,, T. Sirisanthana,, O. Saengwonloey,, and K. E. Nelson. 2001. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin. Infect. Dis. 32:955962.
19. Cimon, B.,, J. Carrere,, J. P. Chazalette,, J. F. Vinatier,, D. Chabasse,, and J. P. Bouchara. 1999. Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis. Med. Mycol. 37:291293.
20.Clinical and Laboratory Standards Institute. 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi: Approved Standard M38-A. CLSI, Wayne, PA.
21. Cooper, C. R., Jr.,, and M. R. McGinnis. 1997. Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch. Pathol. Lab. Med. 121:798804.
22. Costa, C.,, D. Vidaud,, M. Olivi,, E. Bart-Delabesse,, M. Vidaud,, and S. Bretagne. 2001. Development of two realtime quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. J. Microbiol. Methods 44:263269.
23. Dannaoui, E.,, E. Borel,, M. F. Monier,, M. A. Piens,, S. Picot,, and F. Persat. 2001. Acquired itraconazole resistance in Aspergillus fumigatus. J. Antimicrob. Chemother. 47:333340.
24. Debeaupuis, J. P.,, J. Sarfati,, V. Chazalet,, and J. P. Latge. 1997. Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus. Infect. Immun. 65:30803085.
25. De Hoog, G. S.,, J. Guarro,, J. Gene,, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Baarn, The Netherlands.
26. Denning, D. W.,, K. V. Clemons,, L. H. Hanson,, and D. A. Stevens. 1990. Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin. J. Infect. Dis. 162:11511158.
27. Denning, D. W.,, S. A. Radford,, K. L. Oakley,, L. Hall,, E. M. Johnson,, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and invivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401414.
28. Denning, D. W.,, K. Venkateswarlu,, K. L. Oakley,, M. J. Anderson,, N. J. Manning,, D. A. Stevens,, D. W. Warnock,, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:13641368.
29. De Pauw, B.,, T. J. Walsh,, J. P. Donnelly, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:18131821.
30. Desakorn, V.,, M. D. Smith,, A. L. Walsh,, A. J. Simpson,, D. Sahassananda,, A. Rajanuwong,, V. Wuthiekanun,, P. Howe,, B. J. Angus,, P. Suntharasamai,, and N. J. White. 1999. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay. J. Clin. Microbiol. 37:117121.
31. de Valk, H. A.,, J. F. Meis,, I. M. Curfs,, K. Muehlethaler,, J. W. Mouton,, and C. H. Klaassen. 2005. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J. Clin. Microbiol. 43:41124120.
32. Domsch, K. H.,, W. Gams,, and T. H. Anderson. 1980. Compendium of Soil Fungi. IHW-Verlag, Eching, Germany. [Reprint, IHW-Verlag, Eching, Germany, 1993.].
33. Duong, T. A. 1996. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin. Infect. Dis. 23:125130.
34. Einsele, H.,, H. Hebart,, G. Roller,, J. Loffler,, I. Rothenhofer,, C. A. Muller,, R. A. Bowden,, J. van Burik,, D. Engelhard,, L. Kanz,, and U. Schumacher. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35:13531360.
35. Erjavec, Z.,, H. Kluin-Nelemans,, and P. E. Verweij. 2009. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin. Microbiol. Infect. 15:625633.
36. Espinel-Ingroff, A. 2001. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J. Clin. Microbiol. 39:13601367.
37. Ferreira, M. E.,, A. L. Colombo,, I. Paulsen,, Q. Ren,, J. Wortman,, J. Huang,, M. H. Goldman,, and G. H. Goldman. 2005. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med. Mycol. 43(Suppl. 1):S313S319.
38. Fisher, M. C.,, D. Aanensen,, S. de Hoog,, and N. Vanittanakom. 2004. Multilocus microsatellite typing system for Penicillium marneffei reveals spatially structured populations. J. Clin. Microbiol. 42:50655069.
39. Fredricks, D. N.,, C. Smith,, and A. Meier. 2005. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J. Clin. Microbiol. 43:51225128.
40. Girardin, H.,, J. P. Latge,, T. Srikantha,, B. Morrow,, and D. R. Soll. 1993. Development of DNA probes for fingerprinting Aspergillus fumigatus. J. Clin. Microbiol. 31:15471554.
41. Girardin, H.,, J. Sarfati,, F. Traore,, J. Dupouy Camet,, F. Derouin,, and J. P. Latge. 1994. Molecular epidemiology of nosocomial invasive aspergillosis. J. Clin. Microbiol. 32:684690.
42. Gradon, J. D.,, J. G. Timpone,, and S. M. Schnittman. 1992. Emergence of unusual opportunistic pathogens in AIDS: a review. Clin. Infect. Dis. 15:134157.
43. Grossi, P.,, C. Farina,, R. Fiocchi,, and D. Dalla Gasperina. 2000. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Transplantation 70:112116.
44. Hawksworth, D. L. 2009. Separate name for fungus’s sexual stage may cause confusion. Nature 458:29.
45. Hendolin, P. H.,, L. Paulin,, P. Koukila-Kähkölä,, V. J. Anttila,, H. Malmberg,, M. Richardson,, and J. Ylikoski. 2000. Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens. J. Clin. Microbiol. 38:41864192.
46. Herbrecht, R.,, D. W. Denning,, T. F. Patterson,, J. E. Bennett,, R. E. Greene,, J. W. Oestmann,, W. V. Kern,, K. A. Marr,, P. Ribaud,, O. Lortholary,, R. Sylvester,, R. H. Rubin,, J. R. Wingard,, P. Stark,, C. Durand,, D. Caillot,, E. Thiel,, P. H. Chandrasekar,, M. R. Hodges,, H. T. Schlamm,, P. F. Troke,, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408415.
47. Hinrikson, H. P.,, S. F. Hurst,, L. De Aguirre,, and C. J. Morrison. 2005. Molecular methods for the identification of Aspergillus species. Med. Mycol. 43(Suppl. 1):S129S137.
48. Holding, K. J.,, M. S. Dworkin,, P. C. Wan,, D. L. Hanson,, R. M. Klevens,, J. L. Jones,, and P. S. Sullivan. 2000. Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Clin. Infect. Dis. 31:12531257.
49. Hope, W. W.,, T. J. Walsh,, and D. W. Denning. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609622.
50. Hopwood, V.,, E. M. Johnson,, J. M. Cornish,, A. B. Foot,, E. G. Evans,, and D. W. Warnock. 1995. Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J. Clin. Pathol. 48:210213.
51. Horner, W. E.,, A. Helbling,, J. E. Salvaggio,, and S. B. Lehrer. 1995. Fungal allergens. Clin. Microbiol. Rev. 8:161179.
52. Horvath, J. A.,, and S. Dummer. 1996. The use of respiratory- tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am. J. Med. 100:171178.
53. Howard, S. J.,, D. Cerar,, M. J. Anderson,, A. Albarrag,, M. C. Fisher,, A. C. Pasqualotto,, M. Laverdiere,, M. C. Arendrup,, D. S. Perlin,, and D. W. Denning. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:10681076.
54. Ikemura, K.,, K. Ikegami,, T. Shimazu,, T. Yoshioka,, and T. Sugimoto. 1989. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J. Clin. Microbiol. 27:19651968.
55. Iwen, P. C.,, M. E. Rupp,, M. R. Bishop,, M. G. Rinaldi,, D. A. Sutton,, S. Tarantolo,, and S. H. Hinrichs. 1998. Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J. Clin. Microbiol. 36:37133717.
56. Iwen, P. C.,, L. Sigler,, S. Tarantolo,, D. A. Sutton,, M. G. Rinaldi,, R. P. Lackner,, D. I. McCarthy,, and S. H. Hinrichs. 2000. Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia. J. Clin. Microbiol. 38:375381.
57. Johnson, E. M.,, K. L. Oakley,, S. A. Radford,, C. B. Moore,, P. Warn,, D. W. Warnock,, and D. W. Denning. 2000. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J. Antimicrob. Chemother. 45:8593.
58. Kami, M.,, Y. Tanaka,, Y. Kanda,, S. Ogawa,, T. Masumoto,, K. Ohtomo,, T. Matsumura,, T. Saito,, U. Machida,, T. Kashima,, and H. Hirai. 2000. Computed tomographic scan of the chest, latex agglutination test and plasma (1→3)-beta-d-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica 85:745752.
59. Kanda, Y.,, H. Akiyama,, Y. Onozawa,, T. Motegi,, S. Yamagata-Murayama,, and H. Yamaguchi. 1997. Aspergillus endocarditis in a leukemia patient diagnosed by a PCR assay. Kansenshogaku Zasshi 71:269272.
60. Kato, A.,, T. Takita,, M. Furuhashi,, T. Takahashi,, Y. Maruyama,, and A. Hishida. 2001. Elevation of blood (1,3)-beta-d-glucan concentrations in hemodialysis patients. Nephron 89:159.
61. Kaufman, L.,, P. G. Standard,, M. Jalbert,, P. Kantipong,, K. Limpakarnjanarat,, and T. D. Mastro. 1996. Diagnostic antigenemia tests for penicilliosis marneffei. J. Clin. Microbiol. 34:25032505.
62. Kaufman, L.,, P. G. Standard,, M. Jalbert,, and D. E. Kraft. 1997. Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J. Clin. Microbiol. 35:22062209.
63. Klaassen, C. H.,, H. A. de Valk,, S. A. Balajee,, and J. F. Meis. 2009. Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature. J. Microbiol. Methods 77:292296.
64. Klich, M. A. 2002. Identification of Common Aspergillus Species, 1st ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
65. Klich, M. A.,, and J. I. Pitt. 1988. A Laboratory Guide to Common Aspergillus Species and Their Teleomorphs. Commonwealth Scientific and Industrial Research Organization, North Ryde, Australia.
66. Klont, R. R.,, M. A. Mennink-Kersten,, and P. E. Verweij. 2004. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin. Infect. Dis. 39:14671474.
67. Knight, F.,, and D. W. Mackenzie. 1992. Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet 339:188.
68. Kontoyiannis, D. P.,, R. E. Lewis,, G. S. May,, N. Osherov,, and M. G. Rinaldi. 2002. Aspergillus nidulans is frequently resistant to amphotericin B. Mycoses 45:406407.
69. Krasnick, J.,, R. Patterson,, and M. Roberts. 1995. Allergic bronchopulmonary aspergillosis presenting with cough variant asthma and identifiable source of Aspergillus fumigatus. Ann. Allergy Asthma Immunol. 75:344346.
70. Kurtz, M. B.,, I. B. Heath,, J. Marrinan,, S. Dreikorn,, J. Onishi,, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-d-glucan synthase. Antimicrob. Agents Chemother. 38:14801489.
71. Kurup, V. P.,, and A. Kumar. 1991. Immunodiagnosis of aspergillosis. Clin. Microbiol. Rev. 4:439456.
72. Kwon-Chung, K. J.,, and J. E. Bennett. 1992. Medical Mycology. Lea & Febiger, Philadelphia, PA.
73. Lasker, B. A.,, and Y. Ran. 2004. Analysis of polymorphic microsatellite markers for typing Penicillium marneffei isolates. J. Clin. Microbiol. 42:14831490.
74. Lass-Flörl, C.,, E. Gunsilius,, G. Gastl,, H. Bonatti,, M. C. Freund,, A. Gschwendtner,, G. Kropshofer,, M. P. Dierich,, and A. Petzer. 2004. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol. 42:41544157.
75. Lass-Flörl, C.,, P. Rath,, D. Niederwieser,, G. Kofler,, R. Würzner,, A. Krezy,, and M. P. Dierich. 2000. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J. Hosp. Infect. 46:3135.
76. Latge, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310350.
77. Leenders, A.,, A. van Belkum,, S. Janssen,, S. de Marie,, J. Kluytmans,, J. Wielenga,, B. Lowenberg,, and H. Verbrugh. 1996. Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J. Clin. Microbiol. 34:345351.
78. Lin, D.,, P. F. Lehmann,, B. H. Hamory,, A. A. Padhye,, E. Durry,, R. W. Pinner,, and B. A. Lasker. 1995. Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus. J. Clin. Microbiol. 33:15961601.
79. Lindsley, M. D.,, D. W. Warnock,, and C. J. Morrison,. 2006. Serological and molecular diagnosis of fungal infection, p. 569605. In B. Detrick,, R. G. Hamilton,, and J. D. Folds (ed.), Manual of Molecular and Clinical Laboratory Immunology, 7th ed. ASM Press, Washington, DC.
80. Lionakis, M. S.,, and D. P. Kontoyiannis. 2004. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 100:165172.
81. LoBuglio, K. F.,, and J. W. Taylor. 1995. Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. J. Clin. Microbiol. 33:8589.
82. Loeffler, J.,, K. Kloepfer,, H. Hebart,, L. Najvar,, J. R. Graybill,, W. R. Kirkpatrick,, T. F. Patterson,, K. Dietz,, R. Bialek,, and H. Einsele. 2002. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis. J. Infect. Dis. 185:12031206.
83. Lopez-Martinez, R.,, L. Neumann,, and A. Gonzalez- Mendoza. 1999. Case report: cutaneous penicilliosis due to Penicillium chrysogenum. Mycoses 42:347349.
84. Maertens, J.,, K. Buve,, K. Theunissen,, W. Meersseman,, E. Verbeken,, G. Verhoef,, J. Van Eldere,, and K. Lagrou. 2009. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115:355362.
85. Maertens, J.,, K. Theunissen,, G. Verhoef,, J. Verschakelen,, K. Lagrou,, E. Verbeken,, A. Wilmer,, J. Verhaegen,, M. Boogaerts,, and J. Van Eldere. 2005. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin. Infect. Dis. 41:12421250.
86. Maertens, J.,, J. Verhaegen,, H. Demuynck,, P. Brock,, G. Verhoef,, P. Vandenberghe,, J. Van Eldere,, L. Verbist,, and M. Boogaerts. 1999. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme- linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. 37:32233228.
87. Maertens, J.,, J. Verhaegen,, K. Lagrou,, J. Van Eldere,, and M. Boogaerts. 2001. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:16041610.
88. Marques, S. A.,, A. M. Robles,, A. M. Tortorano,, M. A. Tuculet,, R. Negroni,, and R. P. Mendes. 2000. Mycoses associated with AIDS in the Third World. Med. Mycol. 38(Suppl. 1):269279.
89. Marr, K. A.,, S. A. Balajee,, L. McLaughlin,, M. Tabouret,, C. Bentsen,, and T. J. Walsh. 2004. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis. 190:641649.
90. Marr, K. A.,, M. Laverdiere,, A. Gugel,, and W. Leisenring. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40:17621769.
91. Mellado, E.,, G. Garcia-Effron,, M. J. Buitrago,, L. Alcazar- Fuoli,, M. Cuenca-Estrella,, and J. L. Rodriguez-Tudela. 2005. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob. Agents Chemother. 49:25362538.
92. Mengoli, C.,, M. Cruciani,, R. A. Barnes,, J. Loeffler,, and J. P. Donnelly. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:8996.
93. Mennink-Kersten, M. A.,, J. P. Donnelly,, and P. E. Verweij. 2004. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4:349357.
94. Mennink-Kersten, M. A.,, R. R. Klont,, A. Warris,, H. J. Op den Camp,, and P. E. Verweij. 2004. Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet 363:325327.
95. Mennink-Kersten, M. A.,, D. Ruegebrink,, R. R. Klont,, A. Warris,, F. Gavini,, H. J. Op den Camp,, and P. E. Verweij. 2005. Bifidobacterial lipoglycan as a new cause for falsepositive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J. Clin. Microbiol. 43:39253931.
96. Messer, S. A.,, G. J. Moet,, J. T. Kirby,, and R. N. Jones. 2009. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J. Clin. Microbiol. 47:19421946.
97. Miller, W. T. 1996. Aspergillosis: a disease with many faces. Semin. Roentgenol. 31:5266.
98. Moreno, A.,, M. Perez-Elias,, J. Casado,, E. Navas,, V. Pintado,, J. Fortun,, C. Quereda,, and A. Guerrero. 2000. Role of antiretroviral therapy in long-term survival of patients with AIDS-related pulmonary aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 19:688693.
99. Morgan, J.,, K. A. Wannemuehler,, K. A. Marr,, S. Hadley,, D. P. Kontoyiannis,, T. J. Walsh,, S. K. Fridkin,, P. G. Pappas,, and D. W. Warnock. 2005. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med. Mycol. 43(Suppl. 1):S49S58.
100. Musher, B.,, D. Fredricks,, W. Leisenring,, S. A. Balajee,, C. Smith,, and K. A. Marr. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42:55175522.
101. Mylonakis, E.,, M. Paliou,, P. E. Sax,, P. R. Skolnik,, M. J. Baron,, and J. D. Rich. 2000. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review. Medicine (Baltimore) 79:269280.
102. Nakai, T.,, J. Uno,, F. Ikeda,, S. Tawara,, K. Nishimura,, and M. Miyaji. 2003. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob. Agents Chemother. 47:13761381.
103. Nakao, A.,, M. Yasui,, T. Kawagoe,, H. Tamura,, S. Tanaka,, and H. Takagi. 1997. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 44:14131418.
104. Obayashi, T.,, M. Yoshida,, T. Mori,, H. Goto,, A. Yasuoka,, H. Iwasaki,, H. Teshima,, S. Kohno,, A. Horiuchi,, A. Ito, et al. 1995. Plasma (1→3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345:1720.
105. Odabasi, Z.,, V. L. Paetznick,, J. R. Rodriguez,, E. Chen,, and L. Ostrosky-Zeichner. 2004. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob. Agents Chemother. 48:19121915.
106. Onions, A. H. S.,, D. Allsopp,, and H. O. W. Eggins. 1981. Smith’s Introduction to Industrial Mycology. Edward Arnold, London, United Kingdom.
107. Paterson, P. J.,, S. Seaton,, T. D. McHugh,, J. McLaughlin,, M. Potter,, H. G. Prentice,, and C. C. Kibbler. 2006. Validation and clinical application of molecular methods for the identification of molds in tissue. Clin. Infect. Dis. 42:5156.
108. Patterson, T. F. 2002. New agents for treatment of invasive aspergillosis. Clin. Infect. Dis. 35:367369.
109. Patterson, T. F.,, W. R. Kirkpatrick,, M. White,, J. W. Hiemenz,, J. R. Wingard,, B. Dupont,, M. G. Rinaldi,, D. A. Stevens,, and J. R. Graybill. 2000. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 79:250260.
110. Pazos, C.,, J. Ponton,, and A. Del Palacio. 2005. Contribution of (1→3)-beta-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43:299305.
111. Perfect, J. R.,, G. M. Cox,, J. Y. Lee,, C. A. Kauffman,, L. de Repentigny,, S. W. Chapman,, V. A. Morrison,, P. Pappas,, J. W. Hiemenz,, and D. A. Stevens. 2001. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin. Infect. Dis. 33:18241833.
112. Peterson, S. W., 2000. Phylogenetic relationships in Aspergillus based upon rDNA sequence analysis, p. 323355. In R. A. Samson, and J. I. Pitt (ed.), Integration of Modern Taxonomic Methods for Penicillium and Aspergillus Classification. Harwood Academic Publishers, Amsterdam, The Netherlands.
113. Pfaller, M. A. 2000. Antifungal susceptibility testing: progress and future developments. Braz. J. Infect. Dis. 4:5560.
114. Pitt, J. I. 2000. A Laboratory Guide to Common Penicillium Species, 3rd ed. Food Science Australia, North Ryde, Australia.
115. Raper, B. K.,, and D. I. Fennell. 1965. The Genus Aspergillus. The Williams and Wilkins Company, Baltimore, MD.
116. Rath, P. M.,, R. Oeffelke,, K. D. Muller,, and R. Ansorg. 1996. Non-value of Aspergillus antigen detection in bronchoalveolar lavage fluids of patients undergoing bone marrow transplantation. Mycoses 39:367370.
117. Rex, J. H.,, and M. A. Pfaller. 2002. Has antifungal susceptibility testing come of age? Clin. Infect. Dis. 35:982989.
118. Rex, J. H.,, M. A. Pfaller,, T. J. Walsh,, V. Chaturvedi,, A. Espinel-Ingroff,, M. A. Ghannoum,, L. L. Gosey,, F. C. Odds,, M. G. Rinaldi,, D. J. Sheehan,, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643658.
119. Rodriguez-Tudela, J. L.,, L. Alcazar-Fuoli,, E. Mellado,, A. Alastruey-Izquierdo,, A. Monzon,, and M. Cuenca-Estrella. 2008. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:24682472.
120. Sambatakou, H.,, M. Guiver,, and D. Denning. 2003. Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole. Eur. J. Clin. Microbiol. Infect. Dis. 22:681685.
121. Samson, R. A.,, and J. I. Pitt. 2000. Integration of Modern Taxonomic Methods for Penicillium and Aspergillus Classification. Harwood Scientific Publishers, Amsterdam, The Netherlands.
122. Samson, R. A.,, E. S. Hoekstra,, J. C. Frisvad,, and O. Filtenborg. 2002. Introduction to Food and Airborne Fungi, 6th ed. Centraal Bureau voor Schimmelcultures, Utrecht, The Netherlands.
123. Sangoi, A. R.,, W. M. Rogers,, T. A. Longacre,, J. G. Montoya,, E. J. Baron,, and N. Banaei. 2009. Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am. J. Clin. Pathol. 131:364375.
124. Schonheyder, H. 1987. Pathogenetic and serological aspects of pulmonary aspergillosis. Scand. J. Infect. Dis. 51(Suppl.):162.
125. Severens, J. L.,, J. P. Donnelly,, J. F. Meis,, P. F. De Vries Robbe,, B. E. De Pauw,, and P. E. Verweij. 1997. Two strategies for managing invasive aspergillosis: a decision analysis. Clin. Infect. Dis. 25:11481154.
126. Severo, L. C.,, G. R. Geyer,, N. da Silvo Porto,, M. B. Wagner,, and A. T. Londero. 1997. Pulmonary Aspergillus niger intracavitary colonization. Report of 23 cases and a review of the literature. Rev. Iberoam. Micol. 14:104110.
127. Simoneau, E.,, M. Kelly,, A. C. Labbe,, J. Roy,, and M. Laverdiere. 2005. What is the clinical significance of positive blood cultures with Aspergillus sp. in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 35:303306.
128. Snelders, E.,, R. A. Huis In’t Veld,, A. J. Rijs,, G. H. Kema,, W. J. Melchers,, and P. E. Verweij. 2009. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl. Environ. Microbiol. 75:40534057.
129. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332370.
130. Spreadbury, C. L.,, B. W. Bainbridge,, and J. Cohen. 1990. Restriction fragment length polymorphisms in isolates of Aspergillus fumigatus probed with part of the intergenic spacer region from the ribosomal RNA gene complex of Aspergillus nidulans. J. Gen. Microbiol. 136:19911994.
131. Sulahian, A.,, F. Boutboul,, P. Ribaud,, T. Leblanc,, C. Lacroix,, and F. Derouin. 2001. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91:311318.
132. Summerbell, R. C., 2003. Aspergillus, Fusarium, Sporothrix, Piedraia, and their relatives, p. 237498. In D. H. Howard (ed.), Pathogenic Fungi in Humans and Animals. Marcel Dekker, Inc., New York, NY.
133.Reference deleted.
134. Supparatpinyo, K.,, K. E. Nelson,, W. G. Merz,, B. J. Breslin,, C. R. Cooper, Jr., C. Kamwan, and T. Sirisanthana. 1993. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob. Agents Chemother. 37:24072411.
135. Tomee, J. F.,, G. P. Mannes,, W. van der Bij,, T. S. van der Werf,, W. J. deBoer,, G. H. Koeter,, and H. F. Kauffman. 1996. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann. Intern. Med. 125:197201.
136. Vanittanakom, N.,, C. R. Cooper, Jr.,, M. C. Fisher,, and T. Sirisanthana. 2006. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin. Microbiol. Rev. 19:95110.
137. Verweij, P. E.,, K. Brinkman,, H. P. Kremer,, B. J. Kullberg,, and J. F. Meis. 1999. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J. Clin. Microbiol. 37:11861189.
138. Verweij, P. E.,, E. C. Dompeling,, J. P. Donnelly,, A. V. Schattenberg,, and J. F. Meis. 1997. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 25:8689.
139. Verweij, P. E.,, A. J. Rijs,, B. E. De Pauw,, A. M. Horrevorts,, J. A. Hoogkamp-Korstanje,, and J. F. Meis. 1995. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J. Clin. Pathol. 48:474476.
140. Verweij, P. E.,, D. Stynen,, A. J. Rijs,, B. E. de Pauw,, J. A. Hoogkamp-Korstanje,, and J. F. Meis. 1995. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J. Clin. Microbiol. 33:19121914.
141. Vinh, D. C.,, Y. R. Shea,, J. A. Sugui,, E. R. Parrilla- Castellar,, A. F. Freeman,, J. W. Campbell,, S. Pittaluga,, P. A. Jones,, A. Zelazny,, D. Kleiner,, K. J. Kwon-Chung,, and S. M. Holland. 2009. Invasive aspergillosis due to Neosartorya udagawae. Clin. Infect. Dis. 49:102111.
142. Walsh, T. J.,, E. J. Anaissie,, D. W. Denning,, R. Herbrecht,, D. P. Kontoyiannis,, K. A. Marr,, V. A. Morrison,, B. H. Segal,, W. J. Steinbach,, D. A. Stevens,, J. A. van Burik,, J. R. Wingard,, and T. F. Patterson. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327360.
143. Walsh, T. J.,, V. Petraitis,, R. Petraitiene,, A. Field-Ridley,, D. Sutton,, M. Ghannoum,, T. Sein,, R. Schaufele,, J. Peter,, J. Bacher,, H. Casler,, D. Armstrong,, A. Espinel-Ingroff,, M. G. Rinaldi,, and C. A. Lyman. 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188:305319.
144. Walsh, T. J.,, S. Shoham,, R. Petraitiene,, T. Sein,, R. Schaufele,, A. Kelaher,, H. Murray,, C. Mya-San,, J. Bacher,, and V. Petraitis. 2004. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J. Clin. Microbiol. 42:47444748.
145. Warris, A.,, P. Gaustad,, J. F. Meis,, A. Voss,, P. E. Verweij,, and T. G. Abrahamsen. 2001. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J. Hosp. Infect. 47:143148.
146. Warris, A.,, C. H. Klaassen,, J. F. Meis,, M. T. De Ruiter,, H. A. De Valk,, T. G. Abrahamsen,, P. Gaustad,, and P. E. Verweij. 2003. Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains. J. Clin. Microbiol. 41:41014106.
147. Warris, A.,, C. M. Weemaes,, and P. E. Verweij. 2002. Multidrug resistance in Aspergillus fumigatus. N. Engl. J. Med. 347:21732174.
148. Weber, D. J.,, A. Peppercorn,, M. B. Miller,, E. Sickbert- Benett,, and W. A. Rutala. 2009. Preventing healthcareassociated Aspergillus infections: review of recent CDC/ HICPAC recommendations. Med. Mycol. 47(Suppl. 1):S199S209.
149. Weig, M.,, M. Frosch,, K. Tintelnot,, A. Haas,, U. Gross,, B. Linsmeier,, and J. Heesemann. 2001. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatusassociated diseases. J. Clin. Microbiol. 39:17211730.
150. Woitas, R. P.,, J. K. Rockstroh,, A. Theisen,, C. Leutner,, T. Sauerbruch,, and U. Spengler. 1998. Changing role of invasive aspergillosis in AIDS—a case control study. J. Infect. 37:116122.
151. Yamakami, Y.,, A. Hashimoto,, I. Tokimatsu,, and M. Nasu. 1996. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J. Clin. Microbiol. 34:24642468.

Tables

Generic image for table
TABLE 1

Classification of infection

Other fungi discussed in this chapter may present with similar clinical syndromes, and their structures in tissue may resemble those of species.

Citation: Arunmozhi Balajee S, Brandt M. 2011. and , p 1836-1852. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch117
Generic image for table
TABLE 2

Characteristics of some medically important species grown on identification media

Modified from previous versions of this chapter.

Modern concepts have replaced group names with subgenera and sections.

Refer to “Taxonomy” and “Identification” in the section of this chapter for descriptions of terms.

Only species producing potent toxins are noted as toxigenic, but other species may produces toxins of lesser significance.

Citation: Arunmozhi Balajee S, Brandt M. 2011. and , p 1836-1852. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch117

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error